Literature DB >> 25385664

Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts.

Aaron Campigotto1, Samira Mubareka.   

Abstract

Bacterial pneumonia complicating influenza is well-recognized as a severe manifestation of influenza, accounting for a substantial number of deaths from the 1918 influenza pandemic. Influenza-associated bacterial pneumonia remains a major contributor to the burden of influenza, and poses new challenges as antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus spread. We provide an overview of the current state of knowledge of the epidemiology and co-pathogenesis of influenza-associated bacterial pneumonia, and outline management approaches and their limitations. We review preventative measures and discuss implications for pandemic planning. Knowledge gaps are underscored and future research directions are proposed.

Entities:  

Keywords:  bacterial pneumonia; co-pathogenesis; control; influenza virus; transmission

Mesh:

Year:  2014        PMID: 25385664     DOI: 10.1586/14787210.2015.981156

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  6 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients.

Authors:  Paul O Gubbins; Chenghui Li
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

3.  Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2018-12-12       Impact factor: 30.700

4.  Preventing the Risk of Hospitalization for Respiratory Complications of Influenza among the Elderly: Is There a Better Influenza Vaccination Strategy? A Retrospective Population Study.

Authors:  Silvia Cocchio; Tolinda Gallo; Stefania Del Zotto; Elena Clagnan; Andrea Iob; Patrizia Furlan; Marco Fonzo; Chiara Bertoncello; Vincenzo Baldo
Journal:  Vaccines (Basel)       Date:  2020-06-28

Review 5.  Future Biomarkers for Infection and Inflammation in Febrile Children.

Authors:  Judith Zandstra; Ilse Jongerius; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 6.  The immune response to influenza in older humans: beyond immune senescence.

Authors:  Janet E McElhaney; Chris P Verschoor; Melissa K Andrew; Laura Haynes; George A Kuchel; Graham Pawelec
Journal:  Immun Ageing       Date:  2020-05-07       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.